Control-DEX | ||||||
Variable | Group | A | B | C | D | p a |
SpO2 (%) | Control | 81 ± 11 | 82 ± 7.1 | 78 ± 7.8 | 68 ± 11 | a |
DEX | 87 ± 6.0 | 85 ± 7.0 | 82 ± 8.3 | 78 ± 16 | ||
ShO2 (%) | Control | 75 ± 7.5 | 79 ± 5.2 | 72 ± 4.6 | 69 ± 14 | |
DEX | 76 ± 5.9 | 76 ± 6.1 | 74 ± 8.1 | 68 ± 17 | a | |
Portal vein lactate (mmol/L) | Control | 2.0 ± 0.5 | 4.2 ± 1.4 | 6.4 ± 1.0 | 8.1 ± 1.1 | a |
DEX | 1.7 ± 0.5 | 2.9 ± 1.5 | 3.7 ± 1.8* | 6.2 ± 0.9* | a | |
Hepatic vein lactate (mmol/L) | Control | 1.7 ± 0.5 | 4.4 ± 1.7 | 6.0 ± 1.1 | 7.3 ± 1.2 | a |
DEX | 1.4 ± 0.6 | 2.8 ± 1.6 | 3.4 ± 0.4* | 5.8 ± 0.8* | a | |
Total hepatic blood flow (ml/kg/min) | Control | 30 ± 8.8 | 36 ± 5.4 | 28 ± 7.7 | 25 ± 7.9 | a |
DEX | 27 ± 8.1 | 34 ± 5.6 | 23 ± 3.9 | 21 ± 4.9 | ||
Control-ESM | ||||||
Variable | Group | A | B | C | D | p a |
SpO2 (%) | Control | 81 ± 11 | 82 ± 7.1 | 78 ± 7.8 | 68 ± 11 | a |
ESM | 80 ± 6.1 | 79 ± 8.1 | 69 ± 12 | 75 ± 12 | ||
ShO2 (%) | Control | 75 ± 7.5 | 79 ± 5.2 | 72 ± 4.6 | 69 ± 14 | |
ESM | 70 ± 11 | 70 ± 16 | 68 ± 12 | 62 ± 23 | ||
Portal vein lactate (mmol/L) | Control | 2.0 ± 0.5 | 4.2 ± 1.4 | 6.4 ± 1.0 | 8.1 ± 1.1 | a |
ESM | 1.1 ± 0.4* | 2.4 ± 0.7* | 2.9 ± 0.9* | 4.0 ± 1.1* | a | |
Hepatic vein lactate (mmol/L) | Control | 1.7 ± 0.5 | 4.4 ± 1.7 | 6.0 ± 1.1 | 7.3 ± 1.2 | a |
ESM | 1.2 ± 0.4* | 2.2 ± 0.6* | 2.8 ± 1.0* | 3.6 ± 1.4* | a | |
Total hepatic blood flow (ml/kg/min) | Control | 30 ± 8.8 | 36 ± 5.4 | 28 ± 7.7 | 25 ± 7.9 | a |
ESM | 39 ± 8.0 | 37 ± 14 | 32 ± 13 | 28 ± 11 |